NEW YORK, Sept. 5 (Xinhua) -- U.S. drugmaker Eli Lilly announced more progress toward a once-weekly insulin shot, weeks after its Danish competitor...
Vous n'êtes pas connecté
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Shares of Eli Lilly closed more than 9% higher on Thursday. The drugmaker now expects revenue for the year […]
NEW YORK, Sept. 5 (Xinhua) -- U.S. drugmaker Eli Lilly announced more progress toward a once-weekly insulin shot, weeks after its Danish competitor...
NEW YORK, Sept. 5 (Xinhua) -- U.S. drugmaker Eli Lilly announced more progress toward a once-weekly insulin shot, weeks after its Danish competitor...
Lululemon lowered its guidance and posted its first revenue miss in more than two years on Thursday after it botched a highly anticipated product...
Updated Date: Thu, 29 Aug 2024 00:00:00 EDT
Obesity medication Zepbound will be available to buy in 2.5-milligram and 5-milligram single-dose vials on manufacturer Eli Lilly's telehealth...
VKTX's shares fell after rival Eli Lilly announced that it is launching cheaper versions of Zepbound to strengthen its presence in the obesity market.
VALCOURT, Que. — BRP Inc. reported its second-quarter profit and revenue fell compared with a year ago and cut its guidance for the year as it said...
VALCOURT, Que. — BRP Inc. reported its second-quarter profit and revenue fell compared with a year ago and cut its guidance for the year as it said...
Updated Date: Thu, 29 Aug 2024 00:00:00 EDT